The appropriate use of biomarkers in heart failure - PubMed (original) (raw)

Review

The appropriate use of biomarkers in heart failure

Punam Chowdhury et al. Med Clin North Am. 2012 Sep.

Abstract

Natriuretic peptides and troponins have been extensively studied and used in heart failure, and their value has been extensively discussed. Renal markers, such as cystasin-C, NGAL, and KIM-1, have shown growing utility in heart failure. The activation of compensatory pathways and ongoing hemodynamic changes result in the release of biomarkers that can be monitored to chart disease progression and possibly target for therapy.

Copyright © 2012 Elsevier Inc. All rights reserved.

PubMed Disclaimer

Publication types

MeSH terms

Substances

LinkOut - more resources